9DC6

Structure of J-PKAc chimera in complex with Aplithianine e1

This is a non-PDB format compatible entry.

Summary for 9DC6

• Entry DOI: 10.2210/pdb9dc6/pdb
• Descriptor: cAMP-dependent protein kinase catalytic subunit alpha, cAMP-dependent protein kinase inhibitor alpha, N-(2-aminoethyl)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4-dihydro-2H-1,4-thiazine-6-carboxamide (3 entities in total)
• Functional Keywords: protein kinase a, fibrolamellar hepatocellular carcinoma, natural product, signaling protein, transferase
• Biological source: Homo sapiens (human); More
• Total number of polymer chains: 4
• Total formula weight: 100085.50

Authors

Martinez Fiesco, J.A.,Zhang, P. (deposition date: 2024-08-25, release date: 2025-07-09)

Primary citation

Du, L.,Wilson, B.A.P.,Moore, W.J.,Dalilian, M.,Shenoy, S.R.,Li, N.,Martinez Fiesco, J.A.,Hwang, J.Y.,Smith, E.A.,Wamiru, A.,Goncharova, E.I.,Alvarez de la Cruz, A.,Pagadala, K.,Piswa, H.K.,Patteti, V.,Jampana, V.P.,Manepalli, P.,Nimmala, R.,Marri, N.R.,Gunuguntla, M.,Reddy, J.J.,Schneekloth Jr., J.S.,Zhang, P.,O'Keefe, B.R.
Chemical Evolution of Aplithianine Class of Serine/Threonine Kinase Inhibitors.
J.Med.Chem., 68:12756-12785, 2025

PubMed Abstract: Chimeric kinase J-PKAcα represents a potential therapeutic target for fibrolamellar hepatocellular carcinoma (FLHCC). Structure-based design and screening were applied to improve the potency of the marine-derived kinase inhibitor aplithianine A targeting J-PKAcα. Three classes of aplithianines (I, II, and III) including >150 analogs were synthesized, significantly improving biochemical IC values to the low nanomolar range. X-ray diffraction experiments confirmed that the class II aplithianines adopted a novel binding mode to J-PKAcα by interacting with the DFG residue Asp239. The kinase selectivity profiles were assessed by kinome profiling. profiles of selected class II analogs were evaluated to determine compound solubility, protein binding, permeability, metabolism, and hERG binding. Selected aplithianine analogs inhibited intracellular phosphorylation of the peptide substrate CREB following stimulation of the J-PKAcα fusion kinase in NIH/3T3 cells and exhibited antiproliferative/cytotoxic activities against select cancer cell lines from the NCI-60 cell panel at nanomolar concentrations.

PubMed: 40476486
DOI: 10.1021/acs.jmedchem.5c00649

Experimental method

X-RAY DIFFRACTION (2.7 Å)